The F50 Global Capital Summit® (Summit) is Silicon Valley’s largest international investor conference. The spread of the coronavirus has highlighted the imperative for new technologies and solutions in the health and medical area. 20+ leaders including leading physicians, investors, and infinluciers had joined the Global Committee which is the volunteering advising board and curation of the content for the summit.  Innovators, leaders and influencers in the startup ecosystem, like you, are vital to accelerating progress worldwide.

Schedule

F50 Global Committee Members

Activities

  • Keynote and thought leader presentation & insightful panels

  • Global Capital Insight Ranking Report

  • F50 Global Awards

  • Speaker & VIP Reception

  • Roundtable Discussions

  • F50 Elevate Connect Lounge (Demo Tables)

Topics

  • Investment

    • Investment trends in Healthtech
    • Early stage opportunities for Angels and seed investors
    • Global impact by Venture Investing
    • Altruism and Capitalism
  • Convergence of Technology in Health

    • The Smarter Medical Devices
    • Innovative Medicines 
    • Future of Surgery
    • Future Virus outbreak prevention and responding
    • Aging and longevity
    • Food tech and innovation
    • DeepTech for Health
  • Corporate Innovation

  • Sustainability cross-border

Keynote Speakers

Current Speakers

Investor Network

Past Partners

Past Attendee Demographics

F50 summits have always been about connecting investors to game-changing founders, startups and technologies, and providing insight on the latest trends from the key players in the startup world. Get your brand in front of 700+ attendees from the top names in the venture capital ecosystem, such as Greylock Partners, Andreessen Horowitz, Sequoia Capital, Menlo Ventures, Khosla Ventures, and more.

ATTENDEE BREAKDOWN

67% Investors

67

8% Global Thought Leaders

8

21% Highly Selected Growth Stage Founders

21

4% Established Unicorns

4

INVESTOR
BREAKDOWN

82% VC executives

82

10% Corporate Ventures

10

8% Long-Term Investors

8

TITLE
PROFILE

23% Managing Partner

23

46% Partner

46

23% CEO/Founder

23

8% Other

8

Tickets